| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 671891 | Null | 0.024789837445214 | -0.34690695 |
| NSC 680553 | 2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester | 0.024789837445214 | 0.68565213 |
| NSC 685685 | 3-Pyridinecarboxylic acid, 4-[2-cyano-2-(ethoxycarbonyl)-1- (2-phenyhydrazino)ethenyl]- | 0.024789837445214 | -0.51104516 |
| NSC 709341 | Null | 0.024789837445214 | -0.3489351 |
| NSC 749117 | 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline | 0.0248868750898605 | -0.19929856 |
| NSC 753218 | 3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline | 0.0248868750898605 | -0.12663627 |
| NSC 754081 | 7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole | 0.0248868750898605 | -0.28493612 |
| NSC 754109 | ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate | 0.0248868750898605 | -0.32440845 |
| NSC 756134 | GSK1023156A | 0.0248868750898605 | -0.22313844 |
| NSC 756233 | GW435821X | 0.0248868750898605 | -0.089515869 |